Skip to main content

Holocene Advisors, LP

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1700574 New York, NY

Position in VRTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,151,504
-$24,042,637 QoQ
Shares Held
12,384
-81.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#439
of 1,735 holders
Holding Since
Mar 2020
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Derivatives in VRTX

reported options exposure · as of Mar 31, 2022
CallValue
$0
CallShares
0
PutValue
$117,775,761
PutShares
451,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Holocene Advisors, LP holds $1,266,200,483 across 29 Biotechnology names. VRTX ranks #17 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VRTX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,151,504 12,384
2026-03-31 $30,194,141 67,618
2025-12-31 $670,066 1,478
2025-06-30 $541,363 1,216
2025-03-31 $589,541 1,216
2024-12-31 $621,366 1,543
2022-06-30 $140,931,632 500,130
2022-03-31 $130,425,237 499,771
2022-03-31 $117,775,761 451,300
2021-06-30 $542,989 2,693
2021-03-31 $1,240,130 5,771
2020-12-31 $891,947 3,774
2020-06-30 $34,300,997 118,153
2020-03-31 $103,933,466 436,787